Back to search

Article

Optimizing the Cumulative Cisplatin Dose for Concurrent Chemoradiotherapy Beneficiaries Among Elderly Nasopharyngeal Carcinoma Patients: A Real World Study

2023-06-29

Abstract excerpt

<title>Abstract</title> <p>Objective This study aimed to find a safe and effective cumulative cisplatin dose (CCD) for concurrent chemoradiotherapy (CCRT) beneficiaries among elderly nasopharyngeal carcinoma (NPC) patients. Materials and methods A total of 765 elderly (≥ 60 years old) NPC patients treated with cisplatin-based CCRT and IMRT-alone from 2007 to 2018 were included in this study. RPA-generated risk...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7a8c9731-aea4-5b28-9ec7-dd73948e83ef
DOI
10.21203/rs.3.rs-3088071/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Optimizing the Cumulative Cisplatin Dose for Concurrent Chemoradiotherapy Beneficiaries Among Elderly Nasopharyngeal Carcinoma Patients: A Real World StudyDOI 10.21203/rs.3.rs-3088071/v1
Select a neighboring publication to make it the new centre.